Predict your next investment

Hedge Fund
redmilegroup.com

See what CB Insights has to offer

Investments

137

Portfolio Exits

66

Funds

6

Service Providers

1

About Redmile Group

Redmile is an asset management group based in San Francisco focused on healthcare investments.

Redmile Group Headquarter Location

One Letterman Drive Building D, Suite D3-300

San Francisco, California, 94129,

United States

415-489-9980

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Redmile Group

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Redmile Group in 1 CB Insights research brief, most recently on Jul 10, 2019.

Latest Redmile Group News

Asia-Pacific’s medical devices industry saw a rise of 4.76% in deal activity during March 2022

Apr 30, 2022

Asia-Pacific’s medical devices industry saw a rise of 4.76% in deal activity during March 2022, when compared with the last 12-month average, led by Fidelity Management & Research, Redmile Group and T Rowe Price Associates’ $125m private equity deal with Saluda Medical, according to GlobalData’s deals database. Embed this chart Embed this chart into your … The post Asia-Pacific’s medical devices industry saw a rise of 4.76% in deal activity during March 2022 appeared first on Medical Device Network.

Redmile Group Investments

137 Investments

Redmile Group has made 137 investments. Their latest investment was in Neuron23 as part of their Series C on March 3, 2022.

CBI Logo

Redmile Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/30/2022

Series C

Neuron23

$100M

No

2

3/2/2022

Series F

Saluda Medical

$125M

No

4

2/16/2022

Series A

Star Therapeutics

$100M

Yes

2

2/16/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

11/9/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

0

Date

3/30/2022

3/2/2022

2/16/2022

2/16/2022

11/9/2021

Round

Series C

Series F

Series A

Series B

Seed VC

Company

Neuron23

Saluda Medical

Star Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$100M

$125M

$100M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

4

2

10

0

Redmile Group Portfolio Exits

66 Portfolio Exits

Redmile Group has 66 portfolio exits. Their latest portfolio exit was Amunix on December 21, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

12/21/2021

Acquired

$99M

10

10/29/2021

IPO

$99M

Public

4

10/29/2021

IPO

$99M

Public

7

9/30/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

8/6/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/21/2021

10/29/2021

10/29/2021

9/30/2021

8/6/2021

Exit

Acquired

IPO

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Public

Subscribe to see more

Subscribe to see more

Sources

10

4

7

10

10

Redmile Group Fund History

6 Fund Histories

Redmile Group has 6 funds, including RedCo I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

5/26/2020

RedCo I

$187.49M

1

3/5/2020

Redmile Biopharma Investments II

Subscribe to see more

Subscribe to see more

$99M

10

7/27/2018

Redmile Biopharma Investments I

Subscribe to see more

Subscribe to see more

$99M

10

12/30/2015

Redmile Private Investments II

Subscribe to see more

Subscribe to see more

$99M

10

Redmile Biopharma Investments III

$99M

10

Closing Date

5/26/2020

3/5/2020

7/27/2018

12/30/2015

Fund

RedCo I

Redmile Biopharma Investments II

Redmile Biopharma Investments I

Redmile Private Investments II

Redmile Biopharma Investments III

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$187.49M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

Redmile Group Service Providers

1 Service Provider

Redmile Group has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

PIPE

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

PIPE

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

Redmile Group Team

8 Team Members

Redmile Group has 8 team members, including current Chief Financial Officer, Joshua Garcia.

Name

Work History

Title

Status

Joshua Garcia

Chief Financial Officer

Current

Bryan R Crapo

Chief Operating Officer

Current

Travis Breznak

Controller

Current

Ming Fang

Managing Director

Current

Rob Faulkner

Managing Director

Current

Name

Joshua Garcia

Bryan R Crapo

Travis Breznak

Ming Fang

Rob Faulkner

Work History

Title

Chief Financial Officer

Chief Operating Officer

Controller

Managing Director

Managing Director

Status

Current

Current

Current

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.